Target intelligence / Profile preview

Reactive isocyanate species

Molecular classification
Other
01

Overview

Reactive isocyanate species are highly electrophilic chemical entities containing the -N=C=O functional group, primarily recognized as potent environmental toxicants and reactive metabolic intermediates rather than therapeutic targets (PubChem). In pharmacology, they are notably generated during the decomposition of nitrosourea-based chemotherapeutics like carmustine, where they contribute to cytotoxicity by carbamoylating proteins and inhibiting DNA repair mechanisms (StatPearls, 2023). Biologically, these species readily form covalent adducts with endogenous proteins like albumin, acting as haptens that can induce a robust immune response, leading to conditions such as occupational asthma and hypersensitivity pneumonitis (Redlich, 2010). Their biological impact is driven by their ability to irreversibly modify lysine residues and other nucleophilic sites, leading to enzyme inhibition and cellular stress (Menges et al., 2012). Consequently, they represent a major safety concern in industrial settings and a source of secondary toxicity in specific medical treatments.

Other names
IsocyanatesIsocyanate groupCarbamoylating speciesNCO compounds
02

Mechanism of action

Reactive isocyanate species act as potent electrophiles that undergo nucleophilic attack by functional groups on proteins (such as lysine amines or cysteine thiols) and nucleic acids, leading to covalent carbamoylation (Menges et al., 2012). This process can inhibit enzyme function, disrupt cellular homeostasis, and create neoantigens that trigger hypersensitivity reactions (Redlich, 2010).

03

Biological functions

Immune responseCell deathOther
04

Disease associations

InflammationOther
05

Safety considerations

Occupational asthmaHypersensitivity pneumonitisChemical-induced lung injurySkin sensitization
06

Interacting drugs

Carmustine

4 more in the full profile.

07

Biomarkers

Isocyanate-specific IgEIsocyanate-albumin adductsUrinary isocyanate metabolites

Beyond the preview

Go deeper on Reactive isocyanate species.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive isocyanate species.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call